Osiris Therapeutics

Leading the way to a better tomorrow Osiris Therapeutics, Inc. is a company founded to commercialize stem cell products from adult bone marrow. These stem cells have demonstrated the ability to repair different types of tissues. The next revolution in medical care Osiris Therapeutics is commercializing products from a readily available and non-controversial source – adult bone marrow. These stem cells have demonstrated the ability to repair different types of tissue and offer a very real opportunity to develop revolutionary new treatments for certain disease processes including autoimmune disorders, heart attacks and arthritis. Osiris’ technology is based on the pioneering work of Dr. Arnold Caplan and his colleagues at Case Western Reserve University. They showed that Mesenchymal Stem Cells (MSCs) can engraft and selectively differentiate, based on the tissue environment, to such lineages as muscle, bone, cartilage, marrow stroma, tendon and fat. Due to their cellular origin and phenotype, these cells do not provoke an immune response, allowing for the development of products derived from unrelated human donors.

Contact Details: 2001 Aliceanna Street Baltimore MD 21231 United States of America Tel: 410 522 5005 Fax: 410 522 6999 Email: osiris@Osiris.com WWW: www.osiris.com/

Loading...

Recent Publications by Osiris Therapeutics:
Purification of sequence-specific DNA-binding proteins by affinity chromatography. The affinity chromatography procedure described in this unit uses DNA...	17th June, 2008	Osiris Therapeutics, Baltimore, Maryland, USA.	Curr Protoc Protein Sci. 2001 May;Chapter 9:Unit 9.6. DOI Direct Link
Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons. Mesenchymal stem cells (MSCs) express low immunogenicity and demonstrate...	19th June, 2007	Osiris Therapeutics, Inc., Baltimore, MD, USA.	Cell Transplant. 2006;15(8-9):711-21.
Donor hematopoietic cells from transgenic mice that express GFP are immunogenic in immunocompetent recipients. OBJECTIVE: To study the immunogenicity of hematopoietic cells marked with...	31st December, 2005	Osiris Therapeutics Inc., 2001 Aliceanna Street, Baltimore, MD 21231, USA.	Hematology. 2005 Aug;10(4):289-95. DOI Direct Link
T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. Human mesenchymal stem cells (MSCs) were evaluated for their ability to...	28th October, 2005	Osiris Therapeutics, Inc., 2001 Aliceanna Street, Baltimore, MD 21231,	J Biomed Sci. 2005;12(1):47-57. DOI Direct Link
A comparative study of biphasic calcium phosphate ceramics for human mesenchymal stem-cell-induced bone formation. For the repair of bone defects, a tissue engineering approach would be to...	21st June, 2005	Osiris Therapeutics,	Biomaterials. 2005 Jun;26(17):3631-8. DOI Direct Link
→View more Osiris Therapeutics research publications.

BioNews Results for Osiris Therapeutics:
Osiris Therapeutics to Present at the JMP Securities Healthcare Focus Conference	Pharma Live:  Oct 5 2008 12:33AM Matching: osiris therapeutics
ImClone Mystery Bidder Revealed	Cafepharma:  Oct 4 2008 4:54AM Matching: osiris therapeutics
Osiris Therapeutics to Present at the JMP Securities Healthcare Focus Conference	DiGiTAL50:  Oct 2 2008 7:26PM Matching: osiris therapeutics
Osiris Therapeutics to Present at the JMP Securities Healthcare Focus Conference	Yahoo!:  Oct 2 2008 12:28PM Matching: osiris therapeutics
Osiris On Prochymal Commercialization	Cafepharma:  Oct 1 2008 8:22AM Matching: osiris therapeutics
Promote your company here: BioNewsCast - Press Release Distribution	→View more Osiris Therapeutics news.

Osiris Therapeutics Patents:
US Patent No.	Title
7153500	Production of megakaryocytes by the use of human mesenchymal stem cells
6281012	Method of preparing suppressor T cells with allogeneic mesenchymal stem cells
6261549	Human mesenchymal stem cells from peripheral blood
6255112	Regulation of hematopoietic stem cell differentiation by the use of human mesenchymal stem cells
6239157	Inhibition of osteoclastogenesis
→View more Osiris Therapeutics patents.

Osiris Therapeutics (OSIR) Financial information Links from Barchart
OSIR Quote from from Barchart.com
OSIR Chart from from Barchart.com
OSIR Profile from from Barchart.com
OSIR Opinion from from Barchart.com
→View more Osiris Therapeutics finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 14 individuals from Osiris Therapeutics using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 283 times since April 2007, the link to the organisation's website has been followed 47 times

Recent Search Terms used to find this page: osiris.com | www.osiris.com | osiris therapeutics | mscs cardiac osiris patent | osiris | osiris therapeutics was founded in | osiris therapeutics | .

Search for more companies in Baltimore

Search for more companies in MD

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Osiris Therapeutics